Proven track record as a biotech innovator. Developed a key technology, restriction enzyme free cloning underlaying the formation of Modular Genetics, Inc. (patent US 20050191623A1),

Joined Symphogen A/S in 2000 as it started its due diligence at start-up. Developed the mammalian expression platform (patent WO/2004/061104) as well had the key idea for the development of the symphogen cognate pair antibody cloning technology as published in 2006(doi:10.1016/j.jmb.2006.02.040).

In his tenure at Symphogen, Vincent helped to make human polyclonal antibodies against tetanus, flu, RhesusD and vaccinia.

In addition to his work at Symphogen, Vincent has served as a long time consultant to the Harvard Physics department and is a Fellow at Harvard University.

Previously, Quinton was the CTO at Clickmarks, an innovative Software startup based in California. Before that he co-invented the SyncML data synchronization standard while working as a software engineer at Lotus/IBM. More recently he worked as a technical leader in the IBM Software Group. In 2004 he was selected to take part in IBM's prestigious Leadership Training program.

Quinton holds a Science Master's degree in Electrical Engineering and Computer Science from MIT in Cambridge, Massachusetts, and two Bachelor's Degrees, one in Mathematics and one in Computer Science from Eckerd College in St. Petersburg, Florida.

Quinton has filed more than 30 software patents, and is excited by the opportunity to apply his leadership skills and creative intellect to the challenge of successfully leading a cutting edge Biotechnology startup.